A comparative study of the pharmacokinetics of ibuprofen arginate versus dexibuprofen in healthy volunteers

European Journal of Clinical Pharmacology

Volumn 62, Issue 10, 2006, Pages 849-854

  Sádaba, Belén ^a   Campanero, Miguel A ^a   Muñoz Juarez, Maria Jose ^a   Gil Aldea, Isabel ^a   García Quetglas, Emilio ^a   Esteras, Antonio ^b   Azanza, Jose R ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b S A Polígono Urvasa   (Spain)

Author keywords

Comparative study; Dexibuprofen; Ibuprofen arginate; Pharmacokinetics

Indexed keywords

ATRISCAL; DEXIBUPROFEN; ESPIDIFEN; IBUPROFEN ARGININE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; EPISTAXIS; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ALGORITHMS; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; ARGININE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; EPISTAXIS; FEMALE; HALF-LIFE; HEADACHE; HUMANS; IBUPROFEN; MALE; METABOLIC CLEARANCE RATE; STEREOISOMERISM; THERAPEUTIC EQUIVALENCY; TIME FACTORS;

EID: 33749484709     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-006-0180-5     Document Type: Article

References (21)

1. Busson M (1986) Update on ibuprofen: review article. J Int Med Res 14:53-62
2. Mehlisch DR, Jasper RD, Brown P, Korn SH, McCarroll K, Murakami AA (1995) Comparative study of ibuprofen lysine and acetaminophen in patients with postoperative dental pain. Clin Ther 17:852-860
3. Fini A, Zecchr V, Tartarini A (1985) Dissolution profiles of NSAID carboxylic acids and their salts with different counter ions. Pharm Acta Helv 60:4
4. Evans AM (2001) Comparative pharmacology of S(+)-ibuprofen and (RS)-ibuprofen. Clin Rheumatol 20(Suppl 1):S9-14
5. Jamali F, Singh NN, Pasutto FM, Russell AS, Coutts RT (1988) Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates. Pharm Res 5:40-43
6. Mehlisch DR, Ardia A, Pallotta T (2002) A controlled comparative study of ibuprofen arginate versus conventional ibuprofen in the treatment of postoperative dental pain. J Clin Pharmacol 42:904-911
7. Fornasini G, Monti N, Brogin G, Gallina M, Eandi M, Persiani S, Bani M, Della Pepa C, Zara G, Strolin Benedetti M (1997) Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers. Chirality 9:297-302
8. Geisslinger G, Schuster O, Stock KP, Loew D, Bach GL, Brune K (1990) Pharmacokinetics of S(+)-and R(-)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis. Eur J Clin Pharmacol 38:493-497
9. Rudy AC, Knight PM, Brater DC, Hall SD (1991) Stereoselective metabolism of ibuprofen in humans: administration of R-, S-and racemic ibuprofen. J Pharmacol Exp Ther 259:1133-1139
10. Geisslinger G, Stock KP, Loew D, Bach GL, Brune K (1993) Variability in the stereoselective disposition of ibuprofen in patients with rheumatoid arthritis. Br J Clin Pharmacol 35:603-607
11. Note for guidance on the investigation of bioavailability and bioequivalence. CPMP/EWP/QWP/1401/98. EMEA. January 2002
12. Hauschke D, Steinijans V, Diletti E (1990) A distribution free procedure for the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 30:37-43
13. White MF (1985) The transport of cationic amino acids across the plasma membrane of mammalian cells. Biochim Biophys Acta 822:355-374
14. Wapnir RA, Wingertzahn MA, Teichberg S (1997) L-arginine in low concentration improves rat intestinal water and sodium absorption from oral rehydration solutions. Gut 40:602-607
15. Ceppi Monti N, Gazzaniga A, Gianesello V, Stroppolo F, Lodola E (1992) Activity and pharmacokinetics of a new oral dosage form of soluble ibuprofen. Arzneimittelforschung 42:556-559
16. Lee EJ, Williams K, Day R, Graham G, Champion D (1985) Stereoselective disposition of ibuprofen enantiomers in man. Br J Clin Pharmacol 19:669-674
17. Gabard B, Nirnberger G, Schiel H, Mascher H, Kikuta C, Mayer JM (1995) Comparison of the bioavailability of dexibuprofen administered alone or as part of racemic ibuprofen. Eur J Clin Pharmacol 48:505-511
18. Jamali F, Mehvar R, Russell AS, Sattari S, Yakimets WW, Koo J (1992) Human pharmacokinetics of ibuprofen enantiomers following different doses and formulations: intestinal chiral inversion. J Pharm Sci 81:221-225
19. Aiba T, Tse MM, Lin ET, Koizumi T (1999) Effect of dosage form on stereoisomeric inversion of ibuprofen in volunteers. Biol Pharm Bull 22:616-622
20. Desjardins P, Black P, Papageorge M, Norwood T, Shen DD, Norris L, Ardia A (2002) Ibuprofen arginate provides effective relief from postoperative dental pain with a more rapid onset of action than ibuprofen. Eur J Clin Pharmacol 58:387-394
21. Black P, Max MB, Desjradins P, Norwood T, Ardia A, Pallotta T (2002) A randomized, double-blind, placebo-controlled comparison of analgesic efficacy, onset of action, and tolerability of Ibuprofen Arginate and Ibuprofen in postoperative dental pain. Clin Ther 24:1072-1089